Delivery Order SPE2DB20D1100-SPE2DB25FC0G4
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$6.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,287.68, is for the delivery of 4,567,956,474 units of the prescription medication lisdexamfetamine 40 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,033,529 units of the prescription medication lisdexamfetamine 30 mg capsules. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $1,976.17 and a performance period through April 28, 2025. Amerisourcebergen Drug Corp also holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lisdexamfetamine 40 mg capsules. The contract has a ceiling value of $1,719.90 and a period of performance through June 23, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,185,890 units of the medication lisdexamfetamine 50 mg capsule in 100-count packages. The $2,584.29 firm fixed-price delivery order has a completion date of May 9, 2025 and is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,699.29. The contract is for the delivery of Lisdexamfetamine 20 mg capsules in 100-count packages. This order is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,280.64, is for the delivery of 4,566,811,802 units of the medication lisdexamfetamine 10 mg capsules. The contract has a firm fixed-price pricing type and an ultimate completion date of December 31, 2024. No set-aside designation is mentioned. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,231.24, is for the supply of Lisdexamfetamine 50 mg capsules to support federal medical requirements. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,092,770 units of the prescription medication lisdexamfetamine 20 mg capsules. The contract has a firm fixed price of $1,547.17 and a completion date of May 1, 2025. This order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10 mg capsules of the medication lisdexamfetamine, a common treatment for ADHD, with a ceiling value of $2,060.30. The contract is a Firm Fixed Price arrangement with a performance period ending on June 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,772.86 delivery order is for the supply of 4,568,059,629 units of the 70 mg Lisdexamfetamine capsule medication. The contract has a firm fixed price pricing type and an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...